| 1 |
Altyar AE, El-Sayed A, Abdeen A, Piscopo M, Mousa SA, Najda A, Abdel-Daim MM. Future regenerative medicine developments and their therapeutic applications. Biomed Pharmacother 2023;158:114131. [PMID: 36538861 DOI: 10.1016/j.biopha.2022.114131] [Reference Citation Analysis]
|
| 2 |
Datta B, Paul D, Dey T, Pal S, Rakshit T. Importance of Extracellular Vesicle Derived RNAs as Critical Colorectal Cancer Biomarkers. ACS Bio Med Chem Au 2022;2:222-35. [DOI: 10.1021/acsbiomedchemau.1c00043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Laggerbauer B, Engelhardt S. MicroRNAs as therapeutic targets in cardiovascular disease. J Clin Invest 2022;132:e159179. [PMID: 35642640 DOI: 10.1172/JCI159179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Zhang Y, Wang D, Wu K, Shao X, Diao H, Wang Z, Sun M, Huang X, Li Y, Tang X, Yan M, Guo J. The Traditional Chinese Medicine Formula FTZ Protects against Cardiac Fibrosis by Suppressing the TGFβ1-Smad2/3 Pathway. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-11. [DOI: 10.1155/2022/5642307] [Reference Citation Analysis]
|
| 5 |
Spadaccio C, Nenna A, Rose D, Piccirillo F, Nusca A, Grigioni F, Chello M, Vlahakes GJ. The Role of Angiogenesis and Arteriogenesisin Myocardial Infarction and Coronary Revascularization. J Cardiovasc Transl Res 2022. [PMID: 35357670 DOI: 10.1007/s12265-022-10241-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Yu CG, Deng Q, Cao S, Zhao ZY, Mei DE, Feng CL, Zhou Q, Chen JL. Ultrasound-targeted cationic microbubbles combined with the NFκB binding motif increase SDF-1α gene transfection: A protective role in hearts after myocardial infarction. Kaohsiung J Med Sci 2022. [PMID: 35324061 DOI: 10.1002/kjm2.12529] [Reference Citation Analysis]
|
| 7 |
Santovito D, Weber C. Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease. Nat Rev Cardiol 2022. [PMID: 35304600 DOI: 10.1038/s41569-022-00680-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Mosbach ML, Pfafenrot C, von Strandmann EP, Bindereif A, Preußer C. Molecular Determinants for RNA Release into Extracellular Vesicles. Cells 2021;10:2674. [PMID: 34685656 DOI: 10.3390/cells10102674] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 9 |
Theofilis P, Vogiatzi G, Oikonomou E, Gazouli M, Siasos G, Katifelis H, Perrea D, Vavuranakis M, Iliopoulos DC, Tsioufis C, Tousoulis D. The Effect of MicroRNA-126 Mimic Administration on Vascular Perfusion Recovery in an Animal Model of Hind Limb Ischemia. Front Mol Biosci 2021;8:724465. [PMID: 34513927 DOI: 10.3389/fmolb.2021.724465] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Theofilis P, Oikonomou E, Vogiatzi G, Antonopoulos AS, Siasos G, Iliopoulos DC, Perrea D, Tsioufis C, Tousoulis D. The impact of proangiogenic microRNA modulation on blood flow recovery following hind limb ischemia. A systematic review and meta-analysis of animal studies. Vascul Pharmacol 2021;:106906. [PMID: 34509635 DOI: 10.1016/j.vph.2021.106906] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 11 |
Kawata K, Koga H, Tsuji K, Miyatake K, Nakagawa Y, Yokota T, Sekiya I, Katagiri H. Extracellular vesicles derived from mesenchymal stromal cells mediate endogenous cell growth and migration via the CXCL5 and CXCL6/CXCR2 axes and repair menisci. Stem Cell Res Ther 2021;12:414. [PMID: 34294118 DOI: 10.1186/s13287-021-02481-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 12 |
Yuan Z, Huang W. New Developments in Exosomal lncRNAs in Cardiovascular Diseases. Front Cardiovasc Med 2021;8:709169. [PMID: 34307511 DOI: 10.3389/fcvm.2021.709169] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 13 |
Huang D, Liu Y, Gao L, Wei X, Xu Y, Cai R, Su Q. MiR-32-3p Regulates Myocardial Injury Induced by Microembolism and Microvascular Obstruction by Targeting RNF13 to Regulate the Stability of Atherosclerotic Plaques. J Cardiovasc Transl Res 2021. [PMID: 34185281 DOI: 10.1007/s12265-021-10150-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 14 |
Dai H, Wang J, Shi Z, Ji X, Huang Y, Zhou R. Predictive value of miRNA-21 on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24966. [PMID: 33725861 DOI: 10.1097/MD.0000000000024966] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 15 |
Saludas L, Oliveira CC, Roncal C, Ruiz-Villalba A, Prósper F, Garbayo E, Blanco-Prieto MJ. Extracellular Vesicle-Based Therapeutics for Heart Repair. Nanomaterials (Basel) 2021;11:570. [PMID: 33668836 DOI: 10.3390/nano11030570] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 16 |
Roberts LB, Kapoor P, Howard JK, Shah AM, Lord GM. An update on the roles of immune system derived microRNAs in cardiovascular diseases. Cardiovasc Res 2021:cvab007. [PMID: 33483751 DOI: 10.1093/cvr/cvab007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
